<DOC>
	<DOC>NCT00914069</DOC>
	<brief_summary>The study will test a hypothesis that the RIVS system will have a higher rate of successful first PIV placement compared to conventional catheter without a significant increase in complications and time of procedure.</brief_summary>
	<brief_title>Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter</brief_title>
	<detailed_description>The hypothesis to be statistically tested was that the RIVS system will have a higher rate of successful first attempt peripheral intravenous placement success as compared to conventional peripheral intravenous catheters without a significant increase in device related complications and procedure time.</detailed_description>
	<criteria>Inclusion Criteria Any type of oncology patients undergoing chemotherapy or postchemotherapy (without a port/cannula), or over 65 years Requires peripheral IV as determined by examining physician Requires the IV when a study nurse or resident is available Able to sign an informed consent Exclusion Criteria Active systemic or cutaneous infection or inflammation; Preexisting immunodeficiency disorder and/or chronic use of systemic steroids; Known, significant history of bleeding diathesis, coagulopathy, von Willebrand's disease or current platelet count &lt; 100,000 cells/mm3, baseline INR â‰¥1.8, or fibrinogen level less than 150 mg/dl (if received a fibrinolytic agent within prior 24 hours); Currently involved in any other investigational clinical trials; Previous vascular grafts or surgery at the target vessel access site; Females who are pregnant, planning to become pregnant within 3 months of the procedure, or lactating; Central line available Requirement for immediate IV placement (patient's condition would potentially be compromised if there is a time delay in IV placement)</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>